Nanoparticle-based intraperitoneal delivery of combined chemo-brachytherapy for treatment of ovarian cancer metastases
Ended Project Grant Awarded Last action
- Award ID
- R41CA239989
- Recipient
-
Nami Therapeutics Corp UEI KNJLDH2XCWG6
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $224,946
Award facts
- Assistance listing
- 93.395 Cancer Treatment Research
- Completion date
- Originally
- Place of performance
- Connecticut, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Amendment | $0 | |
| Original award | $224,946 |
Quick answers
Who received award R41CA239989?
R41CA239989 was awarded to Nami Therapeutics Corp by National Cancer Institute (National Institutes of Health) on September 11, 2019.
How much is award R41CA239989 worth?
$224,946 has been obligated on R41CA239989.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award